# Collegium Pharmaceutical Incorporated

- Location (FDA's records): Cumberland, RI
- FDA decisions: 3 (2009–2010): 3 510(k) clearances
- Product codes: FRO (2), MGQ (1)
- Predicates its devices cite: 8 (1 its own); citations of its devices by later devices: 4 (1 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Stiefel Laboratories, Inc.: 2 (https://510kreport.com/company/stiefel-laboratories)
- Ceragenix Corporation: 1 (https://510kreport.com/company/ceragenix)
- Sinclair Pharmaceuticals, Ltd.: 1 (https://510kreport.com/company/sinclair-pharmaceuticals)
- Ferndale Laboratories, Inc.: 1 (https://510kreport.com/company/ferndale-laboratories)
- Perstorp AB C/O Robert Joel Slomoff: 1 (https://510kreport.com/company/perstorp-ab-c-o-robert-joel-slomoff)
- Triosyn Corp.: 1 (https://510kreport.com/company/triosyn)

## Firms that cite its devices most
- Prugen IP Holdings, Inc.: 2 (https://510kreport.com/company/prugen-ip-holdings)
- Precision Dermatology Incorporated: 1 (https://510kreport.com/company/precision-dermatology)

## Its most-cited devices
- K093051: Hylatopic Plus Emollient Foam (2009), cited by 2
- K083024: Hylatopic Emollient Foam (2009), cited by 2

## Recent decisions
- K093320: Dryodine Cadexomer-Iodine Gel (Jun 18, 2010)
- K093051: Hylatopic Plus Emollient Foam (Dec 7, 2009)
- K083024: Hylatopic Emollient Foam (Mar 27, 2009)

Source page: https://510kreport.com/company/collegium-pharmaceutical